1.Okasha, M, McCarron, P, Gunnell, D, Smith, GD. Exposures in childhood, adolescence and early adulthood and breast cancer risk: a systematic review of the literature. Breast Cancer Res Treat. 2003; 78, 223–276.
2.Burdge, GC, Lillycrop, KA, Jackson, AA. Nutrition in early life, and risk of cancer and metabolic disease: alternative endings in an epigenetic tale? Br J Nutr. 2009; 101, 619–630.
3.Russo, J, Russo, IH. Development of the human breast. Maturitas. 2004; 49, 2–15.
4.Park, SK, Kang, D, McGlynn, KA, et al. Intrauterine environments and breast cancer risk: meta-analysis and systematic review. Breast Cancer Res. 2008; 10, R8.
5.Xu, X, Dailey, AB, Peoples-Sheps, M, et al. Birth weight as a risk factor for breast cancer: a meta-analysis of 18 epidemiological studies. J Womens Health. 2009; 18, 1169–1178.
6.Xue, F, Michels, KB. Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol. 2007; 8, 1088–1100.
7.Martin, RM, Middleton, N, Gunnell, D, Owen, CG, Smith, GD. Breast-feeding and cancer: the Boyd Orr Cohort and a systematic review with meta-analysis. J Natl Cancer Inst. 2005; 97, 1446–1457.
8.Forman, MR, Cantwell, MM, Ronckers, C, Zhang, Y. Through the looking glass at early-life exposures and breast cancer risk. Cancer Invest. 2005; 23, 609–624.
9.Ruder, EH, Dorgan, JF, Kranz, S, Kris-Etherton, PM, Hartman, TJ. Examining breast cancer growth and lifestyle risk factors: early life, childhood, and adolescence. Clin Breast Cancer. 2008; 8, 334–342.
10.Barba, M, McCann, SE, Nie, J, et al. Perinatal exposures and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer Causes Control. 2006; 17, 395–401.
11.Green, J, Cairns, BJ, Casabonne, D, et al, for the Million Women Study collaborators.Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol. 2011; 12, 785–794.
12.Waterland, RA. Is epigenetics an important link between early life events and adult disease? Horm Res. 2009; (Suppl 1), 13–16.
13.Bernal, AJ, Jirtle, RL. Epigenomic disruption: the effects of early developmental exposures. Birth Defects Res (Part A). 2010; 88, 938–944.
14.Szyf, M, Pakneshan, P, Rabbani, SA. DNA methylation and breast cancer. Biochem Pharmacol. 2004; 68, 1187–1197.
15.Esteller, M. Epigenetics in cancer. N Engl J Med. 2008; 358, 1148–1159.
16.Herman, JG, Merlo, A, Mao, L, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 1995; 55, 4525–4530.
17.Arapshian, A, Kuppumbatti, YS, Mira-y-Lopez, R. Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells. Oncogene. 2000; 19, 4066–4070.
18.Caldeira, JR, Prando, EC, Quevedo, FC, et al. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. BMC Cancer. 2006; 6, 48.
19.Desaulniers, D, Xiao, GH, Lian, H, et al. Effects of mixtures of polychlorinated biphenyls, methylmercury, and organochlorine pesticides on hepatic DNA methylation in prepubertal female Sprague-Dawley rats. Int J Toxicol. 2009; 28, 294–307.
20.Heijmans, BT, Tobi, EW, Stein, AD, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A. 2008; 105, 17046–17049.
21.Tao, MH, Shields, PG, Nie, J, et al. DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat. 2009; 114, 559–568.
22.Tao, MH, Marian, C, Nie, J, et al. Body mass and DNA promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study. Am J Clin Nutr. 2011; 94, 831–838.
23.Mellemkjaer, L, Olsen, ML, Sørensen, HT, et al. Birth weight and risk of early-onset breast cancer (Denmark). Cancer Causes Control. 2003; 14, 61–64.
24.Innes, K, Byers, T, Schymura, M. Birth characteristics and subsequent risk for breast cancer in very young women. Am J Epidemiol. 2000; 152, 1121–1128.
25.Fryer, AA, Emes, RD, Ismail, KM, et al. Quantitative, high-resolution epigenetic profiling of CpG loci identifies associations with cord blood plasma homocysteine and birth weight in humans. Epigenetics. 2011; 6, 86–94.
26.La Merrill, M, Stein, CR, Landrigan, P, Engel, SM, Savitz, DA. Prepregnancy body mass index, smoking during pregnancy, and infant birth weight. Ann Epidemiol. 2011; 21, 413–420
27.Flom, J, Ferris, J, Gonzalez, K, Santella, R, Terry, M. Prenatal tobacco smoke exposure and genome wide methylation in adulthood. Cancer Epidemiol Biomarkers Prev. 2011; 20, 2518–2523.
28.Breton, CV, Byun, HM, Wenten, M, et al. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am J Respir Crit Care Med. 2009; 180, 462–467.
29.Shah, PS, Ohlsson, A. Knowledge Synthesis group on determinants of low birth weight and preterm births. Effects of prenatal multimicronutrient supplementation on pregnancy outcomes: a meta-analysis. CMAJ. 2009; 180, E99–E108.
30.Attig, L, Gabory, A, Junien, C. Early nutrition and epigenetic programming: chasing shadows. Curr Opin Clin Nutr Metab Care. 2010; 13, 284–293.
31.Freudenheim, JL, Marshall, JR, Graham, S, et al. Exposure to breastmilk in infancy and the risk of breast cancer. Epidemiology. 1995; 5, 324–331.
32.Wise, LA, Titus-Ernstoff, L, Newcomb, PA, et al. Exposure to breast milk in infancy and risk of breast cancer. Cancer Causes Control. 2009; 20, 1083–1089.
33.Michels, KB, Trichopoulos, D, Rosner, BA, et al. Being breastfed in infancy and breast cancer incidence in adult life: results from the two nurses’ health studies. Am J Epidemiol. 2001; 153, 275–283.
34.Titus-Ernstoff, L, Egan, KM, Newcomb, PA, et al. Exposure to breast milk in infancy and adult breast cancer risk. J Natl Cancer Inst. 1998; 90, 921–924.
35.Rodriguez-Palmero, M, Koletzko, B, Kunz, C, Jensen, R. Nutritional and biochemical properties of human milk: II. Lipids, micronutrients, and bioactive factors. Clin Perinatol. 1999; 26, 335–359.
36.Knip, M, Virtanen, SM, Akerblom, HK. Infant feeding and the risk of type 1 diabetes. Am J Clin Nutr. 2010; 91, 1506S–1513S.
37.Kang, GH, Lee, HJ, Hwang, KS, et al. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol. 2003; 163, 1551–1556.
38.Issa, JP, Ahuja, N, Toyota, M, Bronner, MP, Brentnall, TA. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001; 61, 3573–3577.
39.Hsieh, CC, Tzonou, A, Trichopoulos, D. Birth order and breast cancer risk. Cancer Causes Control. 1991; 2, 95–98.
40.Fernandez, SV, Russo, J. Estrogen and xenoestrogens in breast cancer. Toxicol Pathol. 2010; 38, 110–122.
41.Victora, CG, Adair, L, Fall, C, et al. Maternal and Child Undernutrition Study Group. Maternal and child undernutrition: consequences for adult health and human capital. Lancet. 2008; 371, 340–357.
42.Hughes, LA, van den Brandt, PA, de Bruïne, AP, et al. Early life exposure to famine and colorectal cancer risk: a role for epigenetic mechanisms. PLoS One. 2009; 4, e7951.
43.Li, L, Manor, O, Power, C. Early environment and child-to-adult growth trajectories in the 1958 British birth cohort. Am J Clin Nutr. 2004; 80, 185–192.
44.Slanger, T, Mutschelknauss, E, Kropp, S, et al. Test-retest reliability of self-reported reproductive and lifestyle data in the context of a German case-control study on breast cancer and postmenopausal hormone therapy. Ann Epidemiol. 2007; 17, 993–998.
45.Eads, CA, Danenberg, KD, Kawakami, K, et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 2000; 28, E32.
46.Lee, ES, Issa, JP, Roberts, DB, et al. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance. Clin Cancer Res. 2008; 14, 2664–2672.